Evidence map›Paper›PMID 36028438›Full record

ArticleCytotherapy2022

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry.

Daniel J Weiss, Anthony Filiano, Jacques Galipeau, Maroun Khoury, Mauro Krampera, Manoj Lalu, Katarina Le Blanc, Jan Nolta, Donald G Phinney, Patricia R M Rocco and 4 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cytotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniel J WeissUniversity of Vermont College of Medicine, Burlington, Vermont, USA.
Anthony FilianoDepartment of Immunology, Duke University, Durham, North Carolina, USA; Marcus Center for Cellular Cures, Duke University, Durham, North Carolina, USA; Department of Pathology, Duke University, Durham, North Carolina, USA; Department of Neurosurgery, Duke University, Durham, North Carolina, USA.
Jacques GalipeauDepartment of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Maroun KhouryIMPACT-Center for Interventional Medicine for precision and advanced cellular therapy, Universidad de los Andes, Santiago, Chile; Cells for Cells and Consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.
Mauro KramperaDepartment of Medicine, Section of Hematology, University of Verona, Verona, Italy.
Manoj LaluCellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada; Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Katarina Le BlancDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
Jan NoltaDepartment of Internal Medicine, Stem Cell Program and Institute for Regenerative Cures, University of California Davis, Sacramento, California, USA.
Donald G PhinneyUF Scripps Biomedical Research, Jupiter, Florida, USA.
Patricia R M RoccoLaboratory of Pulmonary Investigation, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Yufang ShiThe First Affiliated Hospital, Soochow University Institutes for Translational Medicine, Suzhou, China; Institute of Health Sciences, Chinese Academy of Sciences, Shanghai, China.
Karin TarteUMR U1236-MICMAC, Immunology and Cell Therapy Lab, Rennes University Hospital, Rennes, France.
Sowmya ViswanathanOsteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Canada; Krembil Research Institute, University Health Network, Toronto, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Canada; Department of Medicine, Division of Hematology, University of Toronto, Toronto, Canada.
Ivan MartinDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationClinical Trials as TopicGenetic TherapyHumansRegistries

Identifiers

PMID36028438
PMCPMC9339970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.